Glyxambi

Glyxambi Indications/Uses

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
GLYXAMBI is indicated to improve glycaemic control in adults with type 2 diabetes mellitus: instead of empagliflozin, when diet, exercise and treatment with empagliflozin ± metformin do not provide adequate glycaemic control; instead of linagliptin, when diet, exercise and treatment with linagliptin ± metformin do not provide adequate glycaemic control.
GLYXAMBI can be used to replace the free combination of empagliflozin and linagliptin in adult patients with type 2 diabetes mellitus who are already being treated with this combination.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in